nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Animal versus human oral drug bioavailability: Do they correlate?
|
Musther, Helen |
|
2014 |
57 |
C |
p. 280-291 12 p. |
artikel |
2 |
A review of drug solubility in human intestinal fluids: Implications for the prediction of oral absorption
|
Augustijns, Patrick |
|
2014 |
57 |
C |
p. 322-332 11 p. |
artikel |
3 |
Bio-predictive tablet disintegration: Effect of water diffusivity, fluid flow, food composition and test conditions
|
Radwan, Asma |
|
2014 |
57 |
C |
p. 273-279 7 p. |
artikel |
4 |
Bio-relevant dissolution testing of hard capsules prepared from different shell materials using the dynamic open flow through test apparatus
|
Garbacz, Grzegorz |
|
2014 |
57 |
C |
p. 264-272 9 p. |
artikel |
5 |
Calendar Of Events
|
|
|
2014 |
57 |
C |
p. 367- 1 p. |
artikel |
6 |
Cinnarizine food-effects in beagle dogs can be avoided by administration in a Self Nano Emulsifying Drug Delivery System (SNEDDS)
|
Christiansen, Martin Lau |
|
2014 |
57 |
C |
p. 164-172 9 p. |
artikel |
7 |
13C-labelled microdialysis studies of cerebral metabolism in TBI patients
|
Carpenter, Keri L.H. |
|
2014 |
57 |
C |
p. 87-97 11 p. |
artikel |
8 |
Comparison of microdialysis sampling perfusion fluid components on the foreign body reaction in rat subcutaneous tissue
|
Keeler, Geoffrey D. |
|
2014 |
57 |
C |
p. 60-67 8 p. |
artikel |
9 |
Compound selection for development – Is salt formation the ultimate answer? Experiences with an extended concept of the “100mg approach”
|
Korn, Christian |
|
2014 |
57 |
C |
p. 257-263 7 p. |
artikel |
10 |
Correlation of 3-mercaptopropionic acid induced seizures and changes in striatal neurotransmitters monitored by microdialysis
|
Crick, Eric W. |
|
2014 |
57 |
C |
p. 25-33 9 p. |
artikel |
11 |
Deriving therapies for children with primary CNS tumors using pharmacokinetic modeling and simulation of cerebral microdialysis data
|
Jacus, M.O. |
|
2014 |
57 |
C |
p. 41-47 7 p. |
artikel |
12 |
Development of a bio-relevant dissolution test device simulating mechanical aspects present in the fed stomach
|
Koziolek, Mirko |
|
2014 |
57 |
C |
p. 250-256 7 p. |
artikel |
13 |
Early pharmaceutical profiling to predict oral drug absorption: Current status and unmet needs
|
Bergström, Christel A.S. |
|
2014 |
57 |
C |
p. 173-199 27 p. |
artikel |
14 |
Editorial board members
|
|
|
2014 |
57 |
C |
p. IFC- 1 p. |
artikel |
15 |
Editorial 7th International Symposium on Microdialysis
|
|
|
2014 |
57 |
C |
p. 1- 1 p. |
artikel |
16 |
Effects of verapamil on the pharmacokinetics and hepatobiliary disposition of fexofenadine in pigs
|
Sjögren, Erik |
|
2014 |
57 |
C |
p. 214-223 10 p. |
artikel |
17 |
EUFEPS Pages 2014-02-17
|
|
|
2014 |
57 |
C |
p. I-III nvt p. |
artikel |
18 |
Evaluation of an in vitro faecal degradation method for early assessment of the impact of colonic degradation on colonic absorption in humans
|
Tannergren, Christer |
|
2014 |
57 |
C |
p. 200-206 7 p. |
artikel |
19 |
Fed and fasted state gastro-intestinal in vitro lipolysis: In vitro in vivo relations of a conventional tablet, a SNEDDS and a solidified SNEDDS
|
Christophersen, Philip Carsten |
|
2014 |
57 |
C |
p. 232-239 8 p. |
artikel |
20 |
Identification of human cerebrospinal fluid proteins and their distribution in an in vitro microdialysis sampling system
|
Wetterhall, Magnus |
|
2014 |
57 |
C |
p. 34-40 7 p. |
artikel |
21 |
In vitro microdialysis recovery and delivery investigation of cytokines as prerequisite for potential biomarker profiling
|
Kirbs, Claudia |
|
2014 |
57 |
C |
p. 48-59 12 p. |
artikel |
22 |
In vitro models for the prediction of in vivo performance of oral dosage forms
|
Kostewicz, Edmund S. |
|
2014 |
57 |
C |
p. 342-366 25 p. |
artikel |
23 |
In vivo methods for drug absorption – Comparative physiologies, model selection, correlations with in vitro methods (IVIVC), and applications for formulation/API/excipient characterization including food effects
|
Sjögren, Erik |
|
2014 |
57 |
C |
p. 99-151 53 p. |
artikel |
24 |
Is the full potential of the biopharmaceutics classification system reached?
|
Bergström, Christel A.S. |
|
2014 |
57 |
C |
p. 224-231 8 p. |
artikel |
25 |
Microdialysis sampling techniques applied to studies of the foreign body reaction
|
Sides, Cynthia R. |
|
2014 |
57 |
C |
p. 74-86 13 p. |
artikel |
26 |
Oral biopharmaceutics-current status and identified gaps of understanding
|
Lennernäs, Hans |
|
2014 |
57 |
C |
p. 98- 1 p. |
artikel |
27 |
Oral biopharmaceutics tools – Time for a new initiative – An introduction to the IMI project OrBiTo
|
Lennernäs, H. |
|
2014 |
57 |
C |
p. 292-299 8 p. |
artikel |
28 |
PBPK models for the prediction of in vivo performance of oral dosage forms
|
Kostewicz, Edmund S. |
|
2014 |
57 |
C |
p. 300-321 22 p. |
artikel |
29 |
Population pharmacokinetics meets microdialysis: Benefits, pitfalls and necessities of new analysis approaches for human microdialysis data
|
Schaeftlein, André |
|
2014 |
57 |
C |
p. 68-73 6 p. |
artikel |
30 |
Prediction of methotrexate CNS distribution in different species – Influence of disease conditions
|
Westerhout, Joost |
|
2014 |
57 |
C |
p. 11-24 14 p. |
artikel |
31 |
Quantitative prediction of formulation-specific food effects and their population variability from in vitro data with the physiologically-based ADAM model: A case study using the BCS/BDDCS Class II drug nifedipine
|
Patel, Nikunjkumar |
|
2014 |
57 |
C |
p. 240-249 10 p. |
artikel |
32 |
Regional intestinal drug permeation: Biopharmaceutics and drug development
|
Lennernäs, Hans |
|
2014 |
57 |
C |
p. 333-341 9 p. |
artikel |
33 |
Rewarding, reinforcing and incentive salient events involve orexigenic hypothalamic neuropeptides regulating mesolimbic dopaminergic neurotransmission
|
Quarta, Davide |
|
2014 |
57 |
C |
p. 2-10 9 p. |
artikel |
34 |
The Biopharmaceutics Classification System: Subclasses for in vivo predictive dissolution (IPD) methodology and IVIVC
|
Tsume, Yasuhiro |
|
2014 |
57 |
C |
p. 152-163 12 p. |
artikel |
35 |
Use of the pentagastrin dog model to explore the food effects on formulations in early drug development
|
Zane, P. |
|
2014 |
57 |
C |
p. 207-213 7 p. |
artikel |